USAID
USAID DIALOGUE ON HIV AND TB PROJECT
Prisoners

Prisoners are believed to have a high prevalence of HIV infection due to high rates of incarceration among injecting drug users as well as drug use in penitentiary facilities. There are an estimated 145,000 prisoners in Central Asia. Sentinel Surveillance highlights a growing HIV epidemic among inmates. Up to 30% of all newly registered HIV infections are registered in prisons. Three countries in the region (Kazakhstan, Kyrgyzstan, and Tajikistan) reported higher prevalence of HIV among inmates in 2007 in comparison to 2006 data. Kazakhstan and Kyrgyzstan have reported the existence of intravenous drug use and coercive sex in the prison system.
 
Prisons have dramatic levels of TB, with a prevalence of TB 35 times higher in prisons in Tajikistan and 65 times higher in prisons in Uzbekistan than in the civilian sector. In Tajikistan, prevalence of TB among prisoners has doubled over the last five years and is approaching 10% of the prison population. About 300 new TB cases are diagnosed annually in the penitentiary system, which corresponds to the incidence rate of about 2,600 per 100,000. Mortality from TB is registered at levels much higher than in the general population. In Kazakhstan, a mortality rate is 55 per 100,000 among prisoners, compared to 17 per 100,000 national average TB mortality.
USAID DIALOGUE ON HIV AND TB PROJECT | 2009 – 2014

USAID Dialogue on HIV and TB Project is one of the many assistance projects supported by the American people through the United States Agency for International Development (USAID). Since 1992, the American people through USAID have provided more than $1.5 billion in programs that support democratic institutions, health care system, education system and economic growth in the Central Asian countries.

This website is made possible by the support of the American people through USAID. The contents are the sole responsibility of PSI and do not necessarily reflect the views of USAID or the United States Government.